Sept. 20, 2018 /CNW/ - 48North Cannabis Corp. ("48North" or the "Company") (TSXV:NRTH) is announcing the completion of Phase I of its project to bring its top performing cannabis cultivars to the Canadian market. Following the importation of 6,650 cannabis seeds from Netherlands-based MariPharm B.V., the Company embarked on a project to select and cultivate its most promising phenotypes at the Company's wholly-owned licensed facility, DelShen Therapeutics Corp. ("DelShen") located in Kirkland Lake, Ontario.
Read more
Rooted in the Netherlands and Grown in Northern Ontario, 48North Cannabis Corp. Announces its Top Six New Cultivars
